Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model

By Nehete P.N.   Chitta S.   Hossain M.M.   Hill L.   Bernacky B.J.   Baze W.   Arlinghaus R.B.   Sastry K.J.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 813-825

Elsevier

Access to resources Recommend Favorite

Modeling the economic benefits of an AIDS vaccine

By Bishai D.   Lin M.K.   Kiyonga C.W.B.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 526-531

Elsevier

Access to resources Recommend Favorite

Engineered Listeria monocytogenes as an AIDS vaccine

By Lieberman J.   Frankel F.R.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 2007-2010

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the Western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection

By Piedra P.A.   Glezen W.P.   Kasel J.A.   Welliver R.C.   Jewel A.M.   Rayford Y.   Hogerman D.A.   Hildreth S.W.   Paradiso P.R.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1095-1101

Elsevier

Access to resources Recommend Favorite

Development of an AIDS vaccine: A daunting epidemiological challenge

By Nathanson Neal   Mathieson Bonnie  

European Journal of Epidemiology, Vol. 20, Iss. 2, 2005-02 ,pp. : 123-126

Springer Publishing Company

Access to resources Recommend Favorite